MILLENDO THERAPEUTICS
BioTech/Drugs - Ann Arbor, MI, US
MILLENDO THERAPEUTICS Employees
MILLENDO THERAPEUTICS Details
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing's Syndrome (CS).
MILLENDO THERAPEUTICS Technologies
Email Providers
Outlook
SSL Certificates
Media Temple SSL
Support and Feedback
Zendesk
Email Delivery
Sendgrid
Other
Microsoft Office 365
Search Marketing
Adobe Marketing Cloud